Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This gene represents a non-functional pseudogene that shares sequence homology with the adaptor-related protein complex 2, beta 1 subunit (AP2B1). AP2B1 is essential as a scaffold subunit in the AP-2 adaptor complex for clathrin-mediated endocytosis, facilitating vesicle formation and cargo selection at the plasma membrane[1][3][5]. However, the pseudogene (ENSG00000225191/LOC100131348) contains disruptions such as deletions, insertions, or premature stop codons and does not produce a functional protein, nor does it contribute to any known biological process or serve as a target for therapeutic intervention[2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on adaptor-related protein complex 2 beta 1 subunit pseudogene.